Shanghai Haohai Biological Technology Co Ltd
SSE:688366
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
56.02
113.55
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Shanghai Haohai Biological Technology Co Ltd stock under the Base Case scenario is 101.78 CNY. Compared to the current market price of 68.02 CNY, Shanghai Haohai Biological Technology Co Ltd is Undervalued by 33%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Shanghai Haohai Biological Technology Co Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Shanghai Haohai Biological Technology Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Shanghai Haohai Biological Technology Co Ltd
Balance Sheet Decomposition
Shanghai Haohai Biological Technology Co Ltd
Current Assets | 3.7B |
Cash & Short-Term Investments | 2.7B |
Receivables | 406.1m |
Other Current Assets | 576m |
Non-Current Assets | 3.5B |
Long-Term Investments | 612.4m |
PP&E | 1.7B |
Intangibles | 1.2B |
Other Non-Current Assets | 63.6m |
Current Liabilities | 808.3m |
Accounts Payable | 65m |
Accrued Liabilities | 185.6m |
Short-Term Debt | 26m |
Other Current Liabilities | 531.8m |
Non-Current Liabilities | 745.7m |
Long-Term Debt | 193.2m |
Other Non-Current Liabilities | 552.5m |
Earnings Waterfall
Shanghai Haohai Biological Technology Co Ltd
Revenue
|
2.7B
CNY
|
Cost of Revenue
|
-833.4m
CNY
|
Gross Profit
|
1.9B
CNY
|
Operating Expenses
|
-1.4B
CNY
|
Operating Income
|
464.2m
CNY
|
Other Expenses
|
-18.1m
CNY
|
Net Income
|
446.2m
CNY
|
Free Cash Flow Analysis
Shanghai Haohai Biological Technology Co Ltd
CNY | |
Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Shanghai Haohai Biological Technology Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Score
Shanghai Haohai Biological Technology Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Shanghai Haohai Biological Technology Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Shanghai Haohai Biological Technology Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Shanghai Haohai Biological Technology Co Ltd
According to Wall Street analysts, the average 1-year price target for Shanghai Haohai Biological Technology Co Ltd is 102 CNY with a low forecast of 101 CNY and a high forecast of 105 CNY.
Dividends
Current shareholder yield for Shanghai Haohai Biological Technology Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Shanghai Haohai Biological Technology Co Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Shanghai, Shanghai and currently employs 1,892 full-time employees. The company went IPO on 2015-04-30. Shanghai Haohai Biological Technology Co., Ltd. is a China-based company principally engaged in biological technology-related businesses. The businesses of the Company include the manufacture and sales of biological and medical hyaluronate, the research and development of biological engineering and pharmaceutical products and the provision of related services. Its products include orthopedics products, medical aesthetics and wound care products, ophthalmology products and anti-adhesion and hemostasis products, among others. Orthopedics products include sodium hyaluronate injection, medical chitosan and medical sodium hyaluronate gel. Medical aesthetics and wound care products include recombinant human epidermal growth factor (rhEGF), among others. Ophthalmology products include ophthalmic viscoelastic devices and lubricant eye drops. Anti-adhesion and hemostasis products include medical collagen sponges, among others. The firm mainly operates businesses in Mainland China.
Contact
IPO
Employees
Officers
The intrinsic value of one Shanghai Haohai Biological Technology Co Ltd stock under the Base Case scenario is 101.78 CNY.
Compared to the current market price of 68.02 CNY, Shanghai Haohai Biological Technology Co Ltd is Undervalued by 33%.